Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    20.50 (1.84%)
Bid:
1,129.50
Ask:
1,132.50
Spread: 3.00 (0.266%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Directorate Change

21 Jun 2017 15:19

RNS Number : 7928I
Burberry Group PLC
21 June 2017
 

 Burberry Group plc - Board Changes

The Company is pleased to announce that Jeremy Darroch has been appointed as Senior Independent Director (SID) with effect from 1 July 2017 replacing Philip Bowman who has held this role for a number of years. Jeremy has been a Non-Executive Director since February 2014 and is Chair of the Audit Committee. Philip, who has remained a Director at the request of the Board to provide continuity during a period of significant change, will step down from the Board on 31 October 2017.

 

It will be the responsibility of Jeremy Darroch as the newly appointed SID to lead the process of appointing a successor to Sir John Peace. It is anticipated that a successor will be announced by the end of 2018.

 

Luxury retail expert Ron Frasch has been appointed to the Board as a Non-Executive Director and member of the Remuneration and Nomination Committees, with effect from 1 September 2017. Ron previously held the positions of President and Chief Merchandising Officer, and Vice Chairman of Saks Fifth Avenue Inc. between 2004 and 2013, and was Chief Executive Officer of Bergdorf Goodman Inc. between 2000 and 2004, as well as holding senior positions with other luxury brands. Ron is currently an operating partner of Castanea Partners Inc. a private equity company which is principally focused on investing in branded consumer products and services. He is also a Non-Executive director of Crocs Inc. a NASDAQ company which manufactures innovative casual footwear.

 

Sir John Peace, Chairman, said:

 

"On behalf of the Board I would like to welcome Jeremy to his new role and to thank Philip for his immense contribution to Burberry since the IPO in 2002. The Board and I have greatly appreciated Philip's wise counsel and he will be missed by us all.

 

We are delighted to welcome Ron to the Board. His great understanding of product and broad experience of working with a wide range of luxury brands will be a great asset to Burberry as we continue to focus on delivering long term shareholder value."

 

The Company confirms there is no further information to be disclosed pursuant to LR 9.6.13.

 

21 June 2017

 

Enquiries

Investors and analysts

Charlotte Cowley VP, Investor Relations 020 3367 3524

 

Media

Andrew Roberts VP, Corporate Relations 020 3367 3764

 

Caroline Daniel Brunswick 020 7404 5959

Paul Raeburn Brunswick 020 7404 5959

 

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from any expected future results in forward-looking statements. Burberry Group plc undertakes no obligation to update these forward-looking statements and will not publicly release any revisions it may make to these forward-looking statements that may result from events or circumstances arising after the date of this document. Nothing in this announcement should be construed as a profit forecast. All persons, wherever located, should consult any additional disclosures that Burberry Group plc may make in any regulatory announcements or documents which it publishes. All persons, wherever located, should take note of these disclosures. This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

BURBERRY, the Equestrian Knight Device and the Burberry Check are trademarks belonging to Burberry which are registered and enforced worldwide.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABSGDLRBDBGRB
Date   Source Headline
10th Jun 20264:52 pmRNSDirector Declaration
9th Jun 202611:30 amRNSHolding(s) in Company
1st Jun 202610:15 amRNSIssue of Shares & Total Voting Rights
28th May 202610:45 amRNSAnnual Financial Report
14th May 20267:01 amRNSBoard changes
14th May 20267:00 amRNSBurberry FY26 Preliminary Results
1st May 202612:20 pmRNSIssue of Shares & Total Voting Rights
29th Apr 20262:45 pmRNSDirector Declaration
10th Apr 20263:40 pmRNSHolding(s) in Company
9th Apr 202611:30 amRNSHolding(s) in Company
1st Apr 20265:30 pmRNSIssue of Shares & Total Voting Rights
1st Apr 202612:15 pmRNSHolding(s) in Company
20th Mar 202612:31 pmRNSDirector/PDMR Shareholding
20th Mar 202610:25 amRNSIssue of Equity
19th Mar 20266:00 pmRNSHolding(s) in Company
5th Mar 20264:40 pmRNSHolding(s) in Company
2nd Mar 202611:00 amRNSTotal Voting Rights
12th Feb 20262:00 pmRNSHolding(s) in Company
10th Feb 202610:30 amRNSHolding(s) in Company
2nd Feb 20262:00 pmRNSTotal Voting Rights
27th Jan 20265:00 pmRNSHolding(s) in Company
22nd Jan 202612:30 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSThird Quarter Trading Update
9th Jan 202612:30 pmRNSHolding(s) in Company
2nd Jan 202611:30 amRNSTotal Voting Rights
18th Dec 20252:01 pmRNSHolding(s) in Company
18th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20259:15 amRNSDirector/PDMR Shareholding
2nd Dec 20255:40 pmRNSHolding(s) in Company
1st Dec 20251:30 pmRNSTotal Voting Rights
24th Nov 20255:30 pmRNSHolding(s) in Company
20th Nov 20254:20 pmRNSHolding(s) in Company
19th Nov 20255:36 pmRNSHolding(s) in Company
18th Nov 20256:07 pmRNSHolding(s) in Company
13th Nov 20255:27 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSBurberry Interim Results
3rd Nov 20252:43 pmRNSTotal Voting Rights
28th Oct 20254:50 pmRNSHolding(s) in Company
15th Oct 20255:38 pmRNSHolding(s) in Company
10th Oct 202512:07 pmRNSHolding(s) in Company
2nd Oct 20253:10 pmRNSHolding(s) in Company
1st Oct 202510:30 amRNSTotal Voting Rights
25th Sep 20256:00 pmRNSHolding(s) in Company
5th Sep 20256:21 pmRNSBlock listing Interim Review
5th Sep 20255:45 pmRNSDirector/PDMR Shareholding
1st Sep 202512:14 pmRNSTotal Voting Rights
13th Aug 20253:04 pmRNSHolding(s) in Company
1st Aug 202511:58 amRNSTotal Voting Rights
31st Jul 20254:55 pmRNSDirector/PDMR Shareholding
18th Jul 20255:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.